JOINT FILING AGREEMENTJoint Filing Agreement • July 12th, 2022 • Velan Capital Investment Management LP • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the common stock, par value $0.0001 per share, of Radius Health, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
TERMINATION AGREEMENTTermination Agreement • July 12th, 2022 • Velan Capital Investment Management LP • Pharmaceutical preparations
Each of the undersigned is a party to that certain Joint Filing and Solicitation Agreement, dated as of March 11, 2022, as amended on April 18, 2022 and May 24, 2022 (as amended, the “Joint Filing and Solicitation Agreement”). In accordance with Section 10 of the Joint Filing and Solicitation Agreement, each of the undersigned hereby agrees that the Joint Filing and Solicitation Agreement is terminated effective immediately.
